| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/28/2002 | US20020037860 Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists |
| 03/28/2002 | US20020037859 Antiarthritic agents; antiinflammatory agents |
| 03/28/2002 | US20020037857 Therapy for blood disorders |
| 03/28/2002 | US20020037835 Antitumor agents |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037350 Can be incorporated into various foods and drinks such as table sweeteners, carbonated and non-carbonated beverages, frozen desserts, jellies, cake, bread, candies, chewing gum, an oral composition including tooth paste |
| 03/27/2002 | EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren |
| 03/27/2002 | EP1190713A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/27/2002 | EP1190255A1 Epitopes formed by non-covalent association of conjugates |
| 03/27/2002 | EP1190249A2 Compounds and methods to enhance raav transduction |
| 03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
| 03/27/2002 | EP1189929A2 Factor viia inhibitors |
| 03/27/2002 | EP1189901A1 Oxazaheterocycles as protease inhibitors |
| 03/27/2002 | CN1342167A Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 03/27/2002 | CN1342164A Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 03/27/2002 | CN1342084A Therapeutic compositions containing glutathione analogs |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/26/2002 | US6362341 Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/26/2002 | US6362204 Controlling immunology; antiinflammatory agents |
| 03/26/2002 | US6362166 Protease inhibitor |
| 03/26/2002 | US6362165 Hydroxyphenyl derivatives with HIV integrase inhibitory properties |
| 03/26/2002 | CA2176670C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 03/26/2002 | CA2118136C Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments |
| 03/21/2002 | WO2002022655A1 Glutathione conjugates with distamycin derivatives having antitumoral activity |
| 03/21/2002 | WO2002022571A2 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 03/21/2002 | WO2002022553A2 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | WO2001090138A3 SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING OXAZOLIDINONE DERIVATIVES |
| 03/21/2002 | WO2001087926A3 SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER BY REDUCTIVE ALKYLATION AND CRYSTALLIZATION/ISOLATION IN AQUEOUS METHANOL |
| 03/21/2002 | WO2001079267A3 A glycopeptide and preparation thereof |
| 03/21/2002 | WO2001079193A3 Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| 03/21/2002 | WO2001070672A3 Compounds and methods to treat alzheimer's disease |
| 03/21/2002 | WO2001047469A3 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 03/21/2002 | US20020035239 Active materials for grampositive bacteria, antibiotic resistance infections |
| 03/21/2002 | US20020035115 Thrombin inhibitors |
| 03/21/2002 | US20020035065 Selective MMP inhibitors having reduced side-effects |
| 03/21/2002 | CA2459599A1 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | CA2421786A1 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 03/21/2002 | CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation |
| 03/20/2002 | EP1188767A1 Isolated antioxidant peptides from casein and methods for preparing, isolating and identifying antioxidant peptides |
| 03/20/2002 | EP1188766A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/20/2002 | EP1188765A1 Mechanism oriented inhibitors of dipeptidyl peptidase I |
| 03/20/2002 | EP1187848A1 Annexin derivatives with endogenous chelation sites |
| 03/20/2002 | EP1187847A1 Streptogramin derivatives, preparation and compositions containing them |
| 03/20/2002 | EP1187806A2 Spermine:peptide-based surfactant compounds |
| 03/20/2002 | EP0777680B1 Urokinase receptor ligands |
| 03/20/2002 | CN1341119A Melanocyte-stimulating hormone inhibitors |
| 03/20/2002 | CN1341026A Small peptides and methods for treatment of asthma and inflammation |
| 03/20/2002 | CN1081187C Inhibitors of prenuyl transferases |
| 03/19/2002 | US6359112 Peptides used as agonists and/or inhibitors of amyloid formation and cytotoxicity and also for use in alzheimer's disease, in type II diabetes mellitus and in spongiform encephalophathies |
| 03/19/2002 | US6358234 Absorbent article having deformed hinge and zones of extensibility |
| 03/19/2002 | US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/19/2002 | CA2136330C Technetium-99m labeled peptides for thrombus imaging |
| 03/19/2002 | CA2032303C Inhibitors of retroviral proteases |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020817A1 A method of producing fr901228 |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020557A1 Extended native chemical ligation |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2001085760A8 Thrombin inhibitors |
| 03/14/2002 | WO2001079268A3 A glycopeptide and preparation thereof |
| 03/14/2002 | WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 03/14/2002 | WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 03/14/2002 | US20020032346 Production of mixed acid anhydride and amide compound |
| 03/14/2002 | US20020032175 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | CA2412298A1 Extended native chemical ligation |
| 03/13/2002 | EP1185644A1 Assays for caspase activity using green fluorescent proteins |
| 03/13/2002 | EP1185632A1 Caspase-8 crystals, models and methods |
| 03/13/2002 | EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | CN1340095A Ferfume precursor compositions and method for expressing perfume components |
| 03/13/2002 | CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/12/2002 | US6355809 Method for preparing (2s)-1-(2r3s)-5-chloro-3-(2-chlorophenyl) -1-(3,4-dimethoxy benzene-sulphonyl) 3-hydroxy-2,3-dihydro-1h-indole-2-carbonyl pyrrolidine-2-carboxamide |
| 03/12/2002 | US6355726 Multicomponent ugi reaction; antisense agents, antigens; diagnosis; controlling gene expression by polymeric peptide nucleic acids |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | CA2278608C Method for preparing and purifying an n-alkylated aspartame derivative |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 03/07/2002 | WO2002018378A1 Pyrrolidine derivatives and their use as chymase inhibitor |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002018341A2 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | WO2002017924A1 Method of treatment |
| 03/07/2002 | WO2001060842A3 PROCESS FOR MAKING GRANULATED N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 03/07/2002 | WO2001058471A3 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 03/07/2002 | WO2001055174A3 Universal procedure for refolding recombinant proteins |
| 03/07/2002 | WO2001037194A3 Crystallizable compositions comprising a caspase-7 |
| 03/07/2002 | WO2000071571A8 Fap-activated anti-tumor compounds |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028838 E.g., 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7 hexahydro-pyrazolo-(4,3-c)pyridin-5-yl)-1-(R)-benzyloxymethyl- 2-oxo-ethyl)-isobutyramide; mobility impairments, e.g. identified by balance and gait, in the elderly |